Tumor Lysis Syndrome Associated With Reduced Immunosuppression in a Lung Transplant Recipient

Khan, Behram A.; Deel, Conrad; Hellman, Richard N.
October 2006
Mayo Clinic Proceedings;Oct2006, Vol. 81 Issue 10, p1397
Academic Journal
Tumor lysis syndrome usually occurs after initiation of chemotherapy or radiation therapy in cancer patients with a moderate to high tumor burden. To our knowledge, the occurrence of this syndrome after discontinuation or reduction of an immunosuppressive regimen has not been reported in the literature. We describe a patient who had undergone lung transplantation and who was receiving immunosuppression and experienced an episode of acute pancreatitis. During the course of the work-up, the patient was found to have a B-cell lymphoma (posttransplantation lymphoproliferative disease). His tacrolimus dosage was decreased, and azathioprine was discontinued. The patient subsequently developed tumor lysis syndrome. Other than the decrease in immunosuppression, we found no other factor that could have accounted for this syndrome.


Related Articles

  • A male patient with malignant lymphoma and thyroid papillary carcinoma after pediatric renal transplantation. Motoyama, Osamu; Takasu, Jiro; Kawamura, Takeshi; Aikawa, Atushi; Shigetomi, Yukari; Nara, Chiharu; Ohara, Akira; Iitaka, Kikuo; Hasegawa, Akira // Clinical & Experimental Nephrology;Feb2010, Vol. 14 Issue 1, p94 

    A 6-year-old boy received renal transplantation and was treated with methylprednisolone, cyclosporine A and mizoribine. He developed Epstein–Barr virus-associated malignant lymphoma at 10 years and thyroid papillary carcinoma at 20 years of age. Chemotherapy for the malignant lymphoma was...

  • Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. E.-K. Song; S.-Y. Kim; T. M. Kim; K.-W. Lee; T. Yun; I.-I. Na; H. Shin; S. H. Lee; D. W. Kim; S. I. Khwarg; D. S. Heo // Annals of Oncology;Feb2008, Vol. 19 Issue 2, p242 

    Background: Radiotherapy is commonly used as a first-line treatment for localized ocular adnexal extranodal marginal zone B-cell lymphoma (EMZBL), despite its ophthalmologic complications. This study was undertaken to analyze the efficacy of first-line chemotherapy in treating EMZBL....

  • Diffuse Large B-cell lymphoma.  // Encyclopedic Reference of Cancer;2001, p251 

    A definition of the term "diffuse large B-cell lymphoma" is presented. It refers to the most common subcategory of NHL, but apparently a heterogeneous subgroup in terms of cell morphology, genetic abnormality and clinical pictures. The disease shows an aggressive clinical behavior, but is...

  • Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis. Rossi, Barbara; Schinzari, Giovanni; Maccauro, Giulio; Scaramuzzo, Laura; Signorelli, Diego; Rosa, Michele A.; Fabbriciani, Carlo; Carlo, Barone // BMC Musculoskeletal Disorders;2010, Vol. 11, p34 

    Background: Angiogenesis plays a role in the progression of osteosarcoma, as well as in other mesenchymal tumors and carcinomas, and it is most commonly assessed by vascular endothelial growth factor (VEGF) expression or tumor CD31-positive microvessel density (MVD). Tumor VEGF expression is...

  • Common Symptoms -- Different Diseases: Coexistence of Neurosyphilis and Non-Hodgkin's Lymphoma. Mantadakis, E.; Samonis, G. // Infection;Feb2002, Vol. 30 Issue 1, p43 

    We describe the case of a 32-year-old man with generalized lymphadenopathy who was diagnosed with a low-grade follicular small-cleaved cell lymphoma. The patient developed hearing loss, tinnitus and cerebrospinal fluid (CSF) pleocytosis attributed to central nervous system (CNS) infiltration by...

  • Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. G. Ryan; G. Martinelli; M. Kuper-Hommel; R. Tsang; G. Pruneri; K. Yuen; D. Roos; A. Lennard; L. Devizzi; S. Crabb; D. Hossfeld; G. Pratt; M. DellOlio; S. P. Choo; R. G. Bociek; J. Radford; S. Lade; A. M. Gianni; E. Zucca; F. Cavalli // Annals of Oncology;Feb2008, Vol. 19 Issue 2, p233 

    Background: Primary diffuse large B-cell lymphoma (DLBCL) of breast is rare. We aimed to define clinical features, prognostic factors, patterns of failure, and treatment outcomes. Patients and methods: A retrospective international study of 204 eligible patients presenting to the International...

  • PeakImmune4. Sellman, Sherrill // Total Health;Mar/Apr2009, Vol. 30 Issue 4, p48 

    The article offers information on the non-toxic immune-modulator PeakImmune4. Aside from strengthening the immune system, the food supplement was found to increase the activity of the body's white blood cells particularly T- and B-cell and especially natural killer (NK) cell function. Apart from...

  • Epstein-Barr-Virus-Positive B-Cell Lymphoma of Recipient Origin Despite of the Elimination of Clonally EBV-Infected T Cells by Allogeneic Stem Cell Transplantation in a Patient with Chronic Active EBV Infection. Nagasawa, Masayuki // Case Reports in Transplantation;2012, p1 

    A 20-year-old patient with chronic active EBV infection (CAEBV) received peripheral blood stem cell transplantation (PBSCT) from HLA-one-locus-mismatched mother. Although EB-virus-infected T cells were eliminated after PBSCT, she developed EBvirus- positive B-cell lymphoma of recipient origin in...

  • Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients. J. Valencak; F. Weihsengruber; K. Rappersberger; F. Trautinger; A. Chott; B. Streubel; L. Muellauer; M. Der-Petrossian; C. Jonak; M. Binder; M. Raderer // Annals of Oncology;Feb2009, Vol. 20 Issue 2, p326 

    Background: We have carried out a retrospective analysis to evaluate the therapeutic value of the anti-CD20 antibody rituximab in 16 consecutive patients with primary cutaneous CD20 B-cell lymphomas. Patients and methods: Sixteen patients (4 females, 12 males) with a median age of 54 years...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics